Lauren Puckett

Antimicrobial Stewardship, Pediatric Infectious Disease Pharmacist at Stanford Children’s Hospital. My views are my own.

[Zayd Ahmad, PharmD, BCIDP @Zaydovudine]

New favorite quote about diagnostic stewardship #IDWeek2023 #IDTwitter

[SIDP @SIDPharm]

Join Dr. @LPthePharmD & team @StanfordPedsASP today at 315pm as they share their findings on ASP review at hospital discharge as a key initiative for promoting optimized therapy

[Lisa Dumkow @LisaIDpharmD]

📣Excited to see this in @ASHE_Journal! No difference in patient outcomes using PO Amox or Cephalexin 1g TID compared to FQ & TMP/SMX for definitive bacteremia treatment from urinary source.

Congrats @geyer_abby & team @DrJaymoGR @THGRPharmRes

Thank you @ABsteward for posting!

[Timothy Li @drtimothyli]

With the latest CLSI breakpoints, tobramycin is the only reliable aminoglycoside for Pseudomonas if you ever need one (Susceptible: MIC ≤1)

Amikacin: can still be used for UTI (Susceptible: MIC ≤ 16)

Gentamicin: RIP ☠️

[SIDP @SIDPharm]

New in @CIDJournal:

"approximately 40% of patients undergoing a major elective surgery did not receive guideline-adherent antimicrobial prophylaxis, largely due to unnecessary use of vancomycin..."

Any ideas to⬆️guideline adherence? #IDTwitter #TwitteRx
https://t.co/HT1coZ4b4g

[ASHE Journal @ASHE_Journal]

From @bpwhite et al: A pharmacist managed OPAT program showed decreased 30 day readmissions for patients on vancomycin as compared to patients not followed by the service.
https://t.co/Xuthr1f2eg

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥APPIC study🔥
2 days of IV antibiotics for pts with complex appendicitis post laparoscopic appendicectomy is non-inferior to 5 days in terms of infectious complications & mortality within 90d, based on a non-inferiority margin of 7·5%
#shorterisbetter
https://t.co/f7YT7JkQav

[Jennifer Girotto @jgirotto3]

We are recruiting for a pediatric ASP pharmacy fellow. Info: https://t.co/5AfIDsEDpb Apply: https://t.co/LAAnD2U26B

[Scott Bergman @bergmanscott]

Wow, can these vaccines look any more similar? @ismp_org What a difference a word makes! @pfizer

[Julie Ann Justo @julie_justo]

@PHUofSCIDFellow First official time I got to teach “HECK Yes.” 🙌🏻 @OncIDPharmd just had to make an appearance…😂

[U.S. FDA @US_FDA]

Today, we revised the EUA for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid. https://t.co/DgCjHkdqgf

[Daniel Crosby @danielcrosby]

I used to drink tons of Diet Coke but it’s been one month since I’ve had a drop.

I want to share some of the changes I’ve observed in myself over that time:

- My health is unchanged
- I’m less happy
- My one source of joy is gone

Thanks for encouraging me on this journey!

[Elaine Liu @liunezolid]

Had a string of these VanC guys back in the wintertime and made a lil cheat sheet for my teams 😌 Vanco more like vancNO 🙅🏻‍♀️

[Krista Gens @kristadgens]

🚨 Our very own 🔥 @LexRX 🔥won the @MnMshp PGY-2 Resident Research Award 🏆 for her preliminary results on the impact of the @sanfordguide Stewardship Assist mobile app at @AllinaHealth! 🥳👏🙌 #proudmom #IDTwitter #TwitteRx @SIDPharm

[Brad Spellberg @BradSpellberg]

Updated Shorter Is Better Tables, thanks to @ABsteward for finding the new RCT of 6 mo all oral Tx for MDR TB, non inferior to > 9 months with an injectable regimen!
https://t.co/1oaAT6koX3

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Super interesting💥
🆕💥Case report @CIDJournal @IDSAInfo
Emergence of dalbavancin, vancomycin, and daptomycin non-susceptible Staphylococcus aureus in a patient treated with dalbavancin #IDTwitter #MedEd #TwitteRx
Wow first time ever to use @CIDJournal https://t.co/o69mvYntS0

[Brad Spellberg @BradSpellberg]

Updated Shorter Is Better tables with new RCT for pediatric CAP. There are now 15 RCTs for CAP having randomized almost 9,000 patients, both kids and adults. It really feels almost like we're just piling on to run up the score at this point!
https://t.co/1oaAT6koX3

[Camille Nelson Kotton @KottonNelson]

Here’s the Evusheld data - risk of symptomatic disease went from 1% to 0.2%. Excellent safety profile. Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 | NEJM https://t.co/iWEgdmIRQf

[Nate Shively @NateShivelyMD]

What works?

Behavioral interventions work.

Great work here from @jeffreylinder and colleagues with the power of the nudge, and showing how powerful peer comparison can be.

[Brad Spellberg @BradSpellberg]

Updated Shorter Is Better tables with the 2 new RCTs @ABsteward found! 1 new post op prophylaxis, shorter was better. 1 new exception, chronic pulmonary aspergillosis (very long was inferior to very very long).
https://t.co/1oaAT6koX3